Betaseron (interferon beta-1b) for Injection, for Subcutaneous Use

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) April 2016 WARNINGS AND PRECAUTIONS Drug-induced Lupus Erythematosus Cases of drug-induced lupus erythematosus have been...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts